Microbicide Trials Network

HPTN 035

A multi-center clinical trial evaluating the safety and effectiveness of two different candidate microbicides, BufferGel® and PRO 2000, in 3,100 sexually active HIV-negative women at seven sites in Africa and the United States.  Results have been reported.  (See news release below.)

See

New findings reported by Microbicide Trials Network at International HIV Prevention Meeting

17-April-2012

  

Microbicide Trials Network statement on the results of MDP 301

14-December-2009

  

Trial finds microbicide promising as HIV prevention method for women

9-February-2009

 

HPTN 035 Backgrounder

9-February-2009

 

HPTN 035 Fact Sheet

9-February-2009 

  

HPTN 035 Q&A

9-February-2009

 

See Also

HPTN 035 Study Protocol

 

NIAID Press Release on HPTN 035 Results

9-February-2009